Risankizumab
Therapeutic Risankizumab antibody from the original Skyrizi® commercial drug.
Reference Standard as Aliquots
Product Batch | Therapeutic Expiry Date
| Brand & Origin
| Amount per Aliquot
| Select Quantity | Discount | Price per Aliquot
| |
|---|---|---|---|---|---|---|---|
2023.04 |
Skyrizi® DE |
6 mg |
Unit: aliquot(s) |
1.066,00 €
/aliquot
|
|||
2024.05 |
Skyrizi® DE |
6 mg |
Unit: aliquot(s) |
1.066,00 €
/aliquot
|
|||
2026.07 |
Skyrizi® DE |
6 mg |
Unit: aliquot(s) |
798,00 €/aliquot
|
|||
2026.11 |
Skyrizi® DE |
6 mg |
Unit: aliquot(s) |
798,00 €/aliquot
|
|||
2026.11 |
Skyrizi® DE |
6 mg |
Unit: aliquot(s) |
197,00 €/aliquot
|
|||
2027.05 |
Skyrizi® DE |
6 mg |
Unit: aliquot(s) |
344,00 €/aliquot
|
Biosimilars as Aliquots
Access Batch Specific Analytical Information
Evidentic’s Analytical Data Service includes a comprehensive array of methods to support the drug development process, including structure, aggregation, degree of isomerization, and N-glycans identification of the active pharmaceutical ingredient (API).
Product Information
Here you will find the product information for the reference product.
Skyrizi® / Risankizumab Reference Product
| Drug name | Skyrizi® |
| INN | Risankizumab |
| API type | Risankizumab is a humanised immunoglobulin G1 (IgG1) monoclonal antibody selective to the interleukin (IL)-23 protein produced in Chinese Hamster Ovary cells using recombinant DNA technology. |
| Pharmacotherapeutic group | Immunosuppressants, interleukin inhibitors. |
| ATC code | L04AC18 |
| Target of antibody | IL-23 |
| General function | Risankizumab is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. |
| Short description | |
| Pharmacodynamic properties (Mechanism of action; Source EMA document) | Risankizumab is a humanised immunoglobulin G1 (IgG1) monoclonal antibody that selectively binds with high affinity to the p19 subunit of human interleukin 23 (IL-23) cytokine without binding to IL-12 and inhibits its interaction with the IL-23 receptor complex. IL-23 is a cytokine that is involved in inflammatory and immune responses. By blocking IL-23 from binding to its receptor, risankizumab inhibits IL-23-dependent cell signalling and release of proinflammatory cytokines. |
| Pharmacodynamic properties (Pharmacodynamic effects; Source EMA document) | In a study of subjects with psoriasis, expression of genes associated with the IL-23/IL-17 axis was decreased in the skin after single doses of risankizumab. Reductions in epidermal thickness, infiltration of inflammatory cells, and expression of psoriatic disease markers were also observed in psoriatic lesions. |
| Original license holder | AbbVie Biotechnology GmbH Knollstrasse 67061 Ludwigshafen Germany |
| Marketing authorisation numbers | EU/1/19/1361/001 |
| Marketing authorisation holder | AbbVie Deutschland GmbH & Co. KG Knollstrasse 67061 Ludwigshafen Germany |
| Name of the manufacturer of the biological active substance | Boehringer Ingelheim Pharma GmbH & Co. KG Birkendorfer Str. 65 88397 Biberach a.d.R. GERMANY and AbbVie Bioresearch Center Inc. 100 Research Drive Worcester MA 01605 USA |
| Name and address of the manufacturer(s) responsible for batch release | AbbVie S.r.l. 148, Pontina Km 52 snc 04011 Campoverde di Aprilia (LT) ITALY and AbbVie Deutschland GmbH & Co. KG Knollstrasse 67061 Ludwigshafen GERMANY |
| Max shelf life | 24 months |
| Storage conditions | 2°C – 8°C |
| List of excipients | Disodium succinate hexahydrate Succinic acid Sorbitol Polysorbate 20 Water for injections |
Support
Do you have a question about the product? Reach out to our team using the form below – we’d be happy to help you!
Ready to simplify your sourcing?
Here’s how to get started:
Select Your Licensed Molecules
Browse our shop and choose the licensed molecule(s) you need. Don’t worry if you can’t find the molecule you’re looking for – we can source it for you!
Get a Quote
Receive a confidential, non-binding quote for the molecule(s) you choose.
Get Qualified & We Deliver
Complete our quick qualification process, place your order, and we’ll ship your molecule(s) within days.
Do you have a question you'd like to ask us?
Here’s how to get started:
